Normanno N, Kim N, Wen D, Smith K, Harris A L, Plowman G, Colletta G, Ciardiello F, Salomon D S
Servizio di Oncologia Sperimentale D, Istituto Nazionale per lo Studio e la Cura dei Tumori-Fondazione Pascale, Napoli, Italy.
Breast Cancer Res Treat. 1995 Sep;35(3):293-7. doi: 10.1007/BF00665981.
The expression of amphiregulin (AR), heregulin (HRG), and cripto-1 (CR-1) mRNA transcripts was assessed in 60 human primary breast carcinoma. AR and HRG transcripts were expressed respectively in 58% and 25% of the carcinomas as measured by Northern blot analysis. CR-1 mRNA was found in 77% of the carcinomas using Reverse Transcriptase-PCR analysis. Coexpression of two or three of these peptides was observed in several specimens. There was no significant association between AR, HRG, and CR-1 expression and nodal status, EGF receptor, or c-erbB-2 protooncogene expression in these tumors. However, a significant association between AR expression and estrogen receptor positivity was observed.
在60例人原发性乳腺癌中评估了双调蛋白(AR)、这里调节素(HRG)和cripto-1(CR-1)mRNA转录物的表达。通过Northern印迹分析测定,AR和HRG转录物分别在58%和25%的癌组织中表达。使用逆转录聚合酶链反应分析在77%的癌组织中发现了CR-1 mRNA。在几个标本中观察到这些肽中的两种或三种的共表达。在这些肿瘤中,AR、HRG和CR-1表达与淋巴结状态、表皮生长因子受体或c-erbB-2原癌基因表达之间没有显著关联。然而,观察到AR表达与雌激素受体阳性之间存在显著关联。